Glimepiride + Metformin Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: Glimepiride 1mg/2mg/3mg/4mg + Metformin 500mg/850mg/1000mg
Reference Brands: Amaryl M
Category:
Diabetes
Glimepiride stimulates insulin release from pancreatic β-cells, while Metformin decreases hepatic glucose production and improves insulin sensitivity. Together, they provide complementary actions for better glycemic control in type 2 diabetes. This dual therapy helps reduce fasting and postprandial blood glucose levels, often with fewer side effects than high-dose monotherapy.
Glimepiride + Metformin Tablet is available in Tablets
and strengths such as Glimepiride 1mg/2mg/3mg/4mg + Metformin 500mg/850mg/1000mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Glimepiride + Metformin Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Glimepiride + Metformin Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Glimepiride + Metformin fixed-dose combination (FDC) tablets are approved in the EU for the management of type 2 diabetes mellitus when monotherapy with either agent is insufficient. EU regulatory bodies support their use based on proven glycemic control efficacy and safety. In the USA, FDCs with Glimepiride are not widely available as branded drugs but may be compounded or prescribed off-label in generic forms. These combinations must meet bioequivalence, labeling, and GMP standards under EMA and FDA guidelines. Pharmatradz.com helps connect buyers with reliable manufacturers offering Glimepiride + Metformin tablets aligned with regional regulatory frameworks.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing